Detection of Allelic Variants of The POLE and POLD1 Genes in Colorectal Cancer Patients

por Pätzold, LA, Bērziņa, D, Daneberga, Z, Gardovskis, J, Miklaševičs, E
Publicado 2017

The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

por Plonis, J, Kalniete, D, Nakazawa-Miklasevica, M, Irmejs, A, Vjaters, E, Gardovskis, J, Miklasevics, E
Publicado 2016

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

por Pullman, J, Gardovskis, J, Farley, B, Sun, E, Quintas, M, Lawrence, L, Ling, R, Cammarata, S
Publicado 2017

Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma

por Vaganovs, P., Bokums, K., Miklaševics, E., Plonis, J., Zarina, L., Geldners, I., Gardovskis, J., Vjaters, E.
Publicado 2013

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population

por Maksimenko, J., Irmejs, A., Trofimovičs, G., Bērziņa, D., Skuja, E., Purkalne, G., Miklaševičs, E., Gardovskis, J.
Publicado 2018

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review

por Loza, P., Irmejs, A., Daneberga, Z., Miklasevics, E., Berga-Svitina, E., Subatniece, S., Maksimenko, J., Trofimovics, G., Tauvena, E., Ukleikins, S., Gardovskis, J.
Publicado 2021